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Background: Anterior knee pain may occur after total knee arthroplasty (TKA). Patellar resurfacing, which is
considered to lower the incidence of anterior knee pain after TKA, remains controversial. In the present study
clinical and radiological outcomes after TKA performed on patients with clinical and radiological signs of
femorotibial and patellofemoral osteoarthritis (OA) with and without patellar resurfacing will be compared.
Methods/design: Fifty patients will be included in a randomized controlled trial. Patients scheduled for TKA
with clinical and radiological signs of femorotibial and patellofemoral OA will be included. Arthritis of the
patellofemoral joint was determined based on the preoperative Baldini and Merchant X-ray views, which is
assessed by the orthopaedic surgeon who treats the patient. Exclusion criteria are rheumatoid arthritis, history of
patellar fracture, tuberosity transposition, high tibial osteotomy (HTO), hip arthroplasty and posterior cruciate ligament
insufficiency. Patients will be randomized to undergo TKA either with or without patellar resurfacing. Outcomes will be
assessed preoperatively, at 6 weeks and at 6, 12, 18 and 24 months postoperatively. Primary outcome measure is the
patellofemoral scoring system according to Baldini. Secondary outcome measures are the Knee Society clinical rating
system (KSS) and the Knee Osteoarthritis Outcome Scale (KOOS) scores. Conventional weight-bearing radiographs, and
views according to Baldini will be used to asses component loosening, wear, and patellofemoral problems including
fracture or loosening of resurfaced patellae, subluxation and wear of non-resurfaced patellae.
Discussion: There is no consensus regarding patellar resurfacing during primary TKA. Current prospective studies
fail to determine any differences in clinical outcome among patients after TKA with or without patellar resurfacing.
This randomized controlled trial has been designed to determine the effectiveness of patellar resurfacing during
TKA in patients undergoing TKA who have clinical and radiological signs of tibiofemoral and patellofemoral OA,
using a specific patellofemoral outcome measurement.
Trial registration: Netherlands Trial Registry NTR3108Background
Total knee arthroplasty (TKA) is a well-established surgi-
cal procedure, effective for relieving pain and improving
function in patients suffering from osteoarthritis of the
knee (OA) [1]. Studies have shown that more than 90% of
modern primary total knee arthroplasties survive for at
least ten years [2,3]. Nonetheless, a substantial number of
patients remains who have patellofemoral pain following
TKA [4,5]. Resurfacing of the patella is considered to be
effective in lowering the incidence of anterior knee pain* Correspondence: t.m.vanraaij@mzh.nl
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reproduction in any medium, provided the or[6,7]. Indications for patellar resurfacing during primary
TKA, as described in current literature [8-11], include
older age, anterior knee pain or other patellofemoral
symptoms, rheumatoid arthritis (RA), obesity, history of
patellar subluxation or dislocation, large and/or thick
patella, a multi-operated knee joint and major loss of
patellofemoral articular cartilage noted intraoperatively.
Patellar resurfacing is not without drawbacks. Compli-
cations of patellar resurfacing include patellar fracture,
tendon rupture, osteonecrosis and soft-tissue impinge-
ment [12-15]. Unsatisfactory results because of patellar
tilt, maltracking, instability, polyethylene wear and patellar
clunk syndrome have been reported [16,17]. Unresurfacedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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may develop cartilage erosion after knee joint replace-
ment [18]. No studies found conclusive evidence that
patellae affected by such changes become symptomatic
after TKA [19,20].
A meta-analysis including 1223 knees showed a 14%
reduction in the absolute risk of postoperative anterior
knee pain following patellar resurfacing during primary
TKA (95% CI: 6–21%) [21]. By resurfacing the patella
during primary TKA the risk of secondary patellar re-
placement was lowered by 5% [6]. Recent reports fail to
demonstrate benefits of patellar resurfacing regarding
functional outcome. Some reports have demonstrated
that secondary patellar resurfacing after TKA leads to
inferior results compared to initial patellar resurfacing
during primary TKA [22-24]. Other prospective stud-
ies fail to determine any difference in clinical and func-
tional outcome among patients after TKA with or
without patellar resurfacing [8,11,25,26]. A recent ran-
domised controlled trial (RCT) including 1715 knees
showed no significant difference in functional outcome
between patellar resurfacing or non-resurfacing during TKA
(95% CI: -0.58–1.76) using the Oxford Knee Score [27].
The inability to detect clinical differences may be
caused by our lack of identifying those individuals who
are thought to benefit from patellar resurfacing whilst
avoiding potential complications [28]. Furthermore,
current scoring systems are unable to detect subtle dif-
ferences in specific patellofemoral pain and function.
The aim of the present study is to create a selective
cohort of patients with clinical and radiological signs of
femorotibial and patellofemoral knee OA who are indi-
cated for TKA. All patients will be scored through the
recent developed Baldini tool, a validated scoring system
specifically designed to evaluate the patellofemoral joint
[29,30]. The hypothesis is that in our cohort of patients
patellar resurfacing will show more than 10% improve-
ment in the Baldini score compared to patients without
patellar resurfacing 24 months after TKA. This paper




The study design is a randomized controlled trial: pa-
tients will be randomly allocated to have TKA with or
without patellar resurfacing. The study will be con-
ducted at the Department of Orthopaedic Surgery of
Martini Hospital Groningen, the Netherlands, a sec-
ondary referral teaching hospital. One investigator will
enroll the patients. Two orthopaedic surgeons will perform
the procedure, and are thus not blinded. One independent
investigator, not involved with enrollment or surgical
procedure, will evaluate the outcome measurements.This investigator and all patients will remain blinded
through the assigned regimen. The study has been
approved by a Medical Ethics Committee, and is also
registered in the Netherlands Trial Registry [Reference
NTRTC3108].
Study sample
Patients suitable for enrolment in the study are candi-
dates for TKA with clinical and radiological signs of
femorotibial and patellofemoral OA. Exclusion criteria
are rheumatoid arthritis, history of patellar fracture,
patellar ligament transposition, high tibial osteotomy
(HTO), hip arthroplasty, posterior cruciate ligament
(PCL) lesion and inability to read or write the Dutch
language.
Intervention
All patients will be operated using the medial parapatel-
lar approach and will receive a posterior cruciate liga-
ment retaining all cemented total knee prosthesis (AGC®
Total Knee System, Biomet, USA). Patella denervation
and osteophyte resection will be performed in all pa-
tients with or without resurfacing [9,10,31]. In the patel-
lar resurfacing group the patella will be resected to the
appropriate size. The posterior articulating surface will
be removed with the patella everted laterally. The re-
section will begin just below the subchondral bone at a
level, which corresponds to the thickness of the patella
component to be implanted. The aim of this procedure
is to ensure maximum coverage of the cut surface with-
out implant overhang. The one-peg all-polyethylene
patellar prosthesis will be cemented in one stage with
the tibial and femoral components. All patients will
have the same postoperative rehabilitation regime.
Main study parameter/endpoint
Primary outcome measure is the patellofemoral scoring
system by Baldini et al. This tool represents patellofe-
moral kinematics more accurately, and may explain
related patellofemoral complaints better [30]. The scoring
system includes objective and subjective aspects concern-
ing the patellofemoral joint, ranging from 0 (worst) to 100
(best) [30].
Secondary study parameters/endpoints
Knee function will be assessed by means of two scoring
systems: the Knee Society clinical rating system (KSS)
and the Knee injury and Osteoarthritis Outcome Score
(KOOS). The KSS is subdivided into a knee score that
rates only aspects of the knee joint itself, such as range
of motion and stability, and a functional score that rates
the patient’s ability to walk and climb stairs [32].The
KOOS is developed as an instrument to assess patients’
opinion about their knee and associated problems [33,34].
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toms, function in daily living, function in sport and
recreation, and knee-related quality of life, with scores
ranging from 0 (worst) to 100 (best).
Component loosening, wear, and patellofemoral prob-
lems including fracture or loosening of resurfaced patel-
lae, subluxation and wear of non-resurfaced patellae
will be assessed on conventional weight-bearing radio-
graphs and views according to Baldini [35]. The view
according to Baldini is a dynamic weight-bearing axial
radiographic view of the patellofemoral joint with the
patient standing in a semi-squatting position with knees
in 45 degrees of flexion (Figure 1) [29].
Randomization
Patients who meet the inclusion criteria will be in-
formed about the study by their orthopaedic surgeon at
the Department of Orthopaedics of Martini Hospital
Groningen. They will be informed about the treatment
and the risk of complications according to the Dutch
Medical Treatment Contracts Act. After consenting to
participate, patients will be randomly assigned to one of
the two regimens in a 1:1 ratio (Figure 2). The scheduleFigure 1 View according to Baldini [29].for randomisation will be randomly generated using a
computer before initiation of the study. To conceal the
outcomes of the randomization, the allocation numbers
will be put into concealed, opaque envelopes. An inde-
pendent researcher will prepare the envelopes. Follow-
ing informed consent, a randomization envelope will be
opened. The randomisation allocation will not be noti-
fied to either the patient or the independent researcher,
as both patient and investigator will be blinded to the
outcome of the randomization.
Data collection methods
Preoperatively as well as at six weeks, and six, 12,18 and
24 months postoperatively patient assessments will be
performed. Age, gender, body mass index (BMI), severity
of OA, will be recorded preoperatively. Perioperative
complications will be registered. Primary and secondary
outcome measurements will be obtained at all time
points by an independent investigator (Table 1).
Sample size calculation
Using the patellofemoral scoring system by Baldini
et al. [30], the sample size is based on a mean difference
of 10 points between both groups at 2-years follow-up.
To detect this difference of 10 points with a standard
deviation of 8 points, alpha of 5% and a power of 90%,
a sample size of 18 patients in each study group is
required. To compensate for potential drop-out and
loss to follow-up, a total of 50 patients will be included
in the study.
Statistical analysis
All statistical analyses will be computed using SPSS
(IBM SPSS, Inc., Version 20.0, 2011). For the clinical
parameters, t-tests will be used for continuous variables
or the Mann–Whitney U-test when the variables are not
normally distributed. A Chi-square test will be used for
dichotomous variables. To assess differences in the
results of the Baldini score and the KOOS over time
between the two study groups, generalised estimating
equations (GEE) analyses will be conducted. Longitu-
dinal data are characterised by repeated observations of
the same subjects. GEE analysis was developed to cor-
rect for repeated outcomes within the same subject
[36]. With a GEE analysis, adjustments for the effect of
differences in patient characteristics on the outcome
variables can also be made by including these variables
as covariates. Both an intention-to-treat analysis as a
per-protocol analysis will be performed.
Discussion
The need to resurface the patella as part of a total knee
arthroplasty (TKA) remains controversial [12,37,38].






Clinical assessment: History, 
examination and 
radiographical (Knee axial, 
lateral, Baldini)
Patients with OA of the 
knee without 
patellofemoral OA 
Patients with OA of the 
knee and patellofemoral 
OA
Figure 2 Flowchart of patient inclusion.
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nificant patellofemoral complaints after TKA, despite
patellar resurfacing [39-41].
Selective resurfacing may improve clinical success by
identifying individuals who will benefit from resurfacingTable 1 Data (time) management
Follow-up X-rays Documentation






Day 1- Day 5 Knee AP and lateral Wound check




Month 12 Knee AP and lateral KSS/Baldini/KOOS
Baldini Physical examination
Month 18 Knee AP and lateral KSS/Baldini/KOOS
Baldini Physical examination
Month 24 Knee AP and lateral KSS/Baldini/KOOS
Baldini Physical examinationthe patella [28]. In the present study all the included
patients will have symptomatic patellofemoral OA as
well as femorotibial OA. In our opinion this selection of
patients provides a cohort that enables us to draw valid
conclusions on patellar resurfacing with the use of the
AGC total knee system. At our department the AGC®
Total Knee System is used. This knee prosthesis has
excellent longevity with minimal wear despite a flat-on-
flat geometry and posterior cruciate ligament retainment
[42,43]. Emerson et al. [43] showed a low rate of patellar
failure in the AGC total knee system. Favourable compo-
nent alignment together with unconstrained patellofe-
moral articulation most likely minimises patellofemoral
stress. However, no specific patellofemoral scoring sys-
tem was used in this study.
Baldini et al. [30] published a scoring system specific-
ally designed to evaluate the patellofemoral joint before
and after TKA. This scoring system is developed to de-
termine function and pain, ranging from 0 to 100 points,
and includes ratings for subjective and objective clinical
aspects of the patellofemoral joint before and after TKA
[30]. This dedicated patellofemoral scoring system will
be used in our clinical trial to improve the accuracy of
the clinical outcome assessment. Feller et al. performed
a prospective study with a self-made specific score for
the patellofemoral joint and arthritis. No significant dif-
ference between the two treatment groups (resurfacing
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Although the study of Feller et al. has a similar design as
the current study, they did not use a homogenous patient
group: by contrast, in the present study all the included
patients will have clinical and radiological femorotibial
and patellofemoral OA [31].
The use of patient selection and a specific validated
measurement tool allow us to expect to find a significant
difference between the two groups that other prospect-
ive trials could not.
Most of these studies use established clinical knee scor-
ing systems, such as the KSS [32] and the KOOS [33] as
outcome assessments. The KSS is derived from clinical
and radiological data and concentrates mainly on the
surgeon’s view of the outcome, i.e. knee pain, joint
deformity and knee motion [44-46]. Patients are more
concerned with symptoms and functional limitations. It is
well recognised that clinical outcome assessments and
patient-related measurements evaluate different aspects of
knee injury and knee OA. Weak correlations and frequent
discordance are found when comparing clinical outcome
assessments like radiographic findings and knee motion to
patient-relevant outcomes such as pain, function and
activity level [47-50].
A patient-reported outcome measure, specific for knee
problems, will thus be used in this study. The KOOS
used in our clinical trial is developed to assess patients'
opinion about their knee and related problems [33]. The
KOOS is a comprehensive instrument that includes five
subscales assessing aspects of knee injury and knee OA
considered important by patients. Most other instru-
ments used for knee functional status combined items
measuring different aspects into one score.
An additional aspect in studies assessing outcome of
TKA is a discrepancy between patellofemoral symptoms
and results obtained by conventional scoring and radio-
graphic analysis [47-49]. Regular scoring systems focus
mainly on tibiofemoral aspects and specific patellofemoral
symptoms can be missed or underscored. Commonly used
clinical outcome measures, such as the KSS, do not take
into account subjective symptoms or objective data specif-
ically arising from the patellofemoral joint. The Baldini
score represents an essential complementary source of in-
formation to the existing KSS and KOOS scores since both
scores do not specifically focus on patellofemoral problems.
Our study design is limited that results may not be
applicable to other knee systems; especially posterior sta-
bilized (PS) TKA. Alternative knee replacement designs
may affect patellar kinematics differently. An in vitro
study, however, showed similar quadriceps forces using
CR or PS TKA systems [51]. To our knowledge no clin-
ical trials have been published to confirm these findings.
Previous randomised controlled trials on the effective-
ness of patellar resurfacing during primary TKA haveincluded patients with knee OA regardless of patellofe-
moral complaints. This trial studies a selected cohort of
patients receiving total knee replacement. All included
patients have clinical and radiological patellofemoral OA
besides symptomatic femorotibial OA. This is a differ-
ence compared to previous randomised controlled trials
that have included patients with knee OA regardless of
patellofemoral complaints.
Radiographic assessments used in clinical trials to evalu-
ate the patellofemoral joint after TKA have remained
basically unchanged for a number of decades, and do not
accurately assess dynamic patellofemoral tracking follow-
ing arthroplasty [52,53]. Traditional radiographic assess-
ment in a static unloaded position may not reproduce
in vivo patellofemoral kinematics [54]. On the commonly
used tangential patellar axial view radiographs, the patellar
position relative to the trochlea is independent of funda-
mental dynamic and neuromuscular factors [55,56]. The
role of the quadriceps muscle in affecting the position of
the patella relative to the femur must be considered.
Additionally, patellar kinematics are influenced by the
axial and rotational alignment of the lower limb [57].
Patients with patellofemoral problems following TKA typ-
ically experience anterior knee pain when the extensor
apparatus is under load. Baldini et al. [30] developed a
dynamic weight-bearing radiographic view that reproduces
a semi-squatting positional setting which sufficiently loads
the patellofemoral joint and involves the extensor appar-
atus. This view according to Baldini will be used in our
clinical trial because it allows for better assessment of
patellofemoral OA and patellar subluxation [29].
Conclusion
This paper describes a novel the design of a randomized
controlled clinical trial on patellar resurfacing during
TKA. A selected group of patients and the use of a specific
patellofemoral scoring system will allow us to identify
patients who will benefit from patellar resurfacing more
accurately [29,30]. This study can contribute to the deci-
sion making of resurfacing or not in primary TKA.
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